Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-amino-1,3,5-triazine-2,4(1h,3h)-dione
2. Ammelide Copper
1. 645-93-2
2. 6-amino-1,3,5-triazine-2,4-diol
3. 6-amino-s-triazine-2,4-diol
4. 6-amino-1,3,5-triazine-2,4(1h,3h)-dione
5. 1,3,5-triazine-2,4(1h,3h)-dione, 6-amino-
6. 6-amino-1h-1,3,5-triazine-2,4-dione
7. 2,4-dihydroxy-6-amino-1,3,5-triazine
8. Dtxsid10214757
9. Nsc-8146
10. Ammedlide
11. J604qc4098
12. 167613-80-1
13. Ammelide-13c3
14. 1,3,5-triazine-2,4-diol,6-amino-(9ci)
15. Melanuric Acid
16. Unii-j604qc4098
17. Nsc 8146
18. Einecs 211-456-7
19. Ammelide; 98%
20. Cyanuric Acid Monoamide
21. Ai3-61038
22. Schembl36691
23. Ammelide, Analytical Standard
24. Chebi:28134
25. Nsc8146
26. Terbuthylazine-tp Mt24 (lm1)
27. Mfcd00049046
28. Stl186172
29. Zinc13529033
30. Akos006222979
31. Akos022175465
32. Sb73399
33. Cid 5281299
34. As-60764
35. 6-azanyl-1h-1,3,5-triazine-2,4-dione
36. Db-054694
37. A0645
38. Ft-0622302
39. C08734
40. T71177
41. 6-amino-2,4-dihydroxy-1,3,5-triazine
42. A834821
43. Q4747226
44. Dihydro-6-imino-1,3,5-triazine-2,4(1h,3h)-dione
45. 6-amino-1,3,5-triazine-2,4(1h,3h)-dione, Aldrichcpr
| Molecular Weight | 128.09 g/mol |
|---|---|
| Molecular Formula | C3H4N4O2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 128.03342538 g/mol |
| Monoisotopic Mass | 128.03342538 g/mol |
| Topological Polar Surface Area | 96.6 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 196 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Ammelide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammelide, including repackagers and relabelers. The FDA regulates Ammelide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammelide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ammelide supplier is an individual or a company that provides Ammelide active pharmaceutical ingredient (API) or Ammelide finished formulations upon request. The Ammelide suppliers may include Ammelide API manufacturers, exporters, distributors and traders.
Ammelide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ammelide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ammelide GMP manufacturer or Ammelide GMP API supplier for your needs.
A Ammelide CoA (Certificate of Analysis) is a formal document that attests to Ammelide's compliance with Ammelide specifications and serves as a tool for batch-level quality control.
Ammelide CoA mostly includes findings from lab analyses of a specific batch. For each Ammelide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ammelide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ammelide EP), Ammelide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ammelide USP).
LOOKING FOR A SUPPLIER?
